Peptide CDMO (Pharmaceutical) Market Deep Research Report with Forecast to 2034

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " “Global Peptide CDMO (Pharmaceutical) Market Trends, Industry Competition Analysis, Company Profiles, Revenue Estimates and Forecast To 2034."

According to the latest market research report, the global Peptide CDMO (Pharmaceutical) Market Size is valued at 2.5 Bn in 2024 and is predicted to reach 6.6 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034.

Request For Free Sample Pages:

https://www.insightaceanalytic.com/request-sample/1202

Peptides, which are short chains of amino acids, play a critical role in addressing unmet medical needs. Peptide-based therapeutics have become integral in the treatment of conditions such as cancer, diabetes, osteoporosis, chronic pain, multiple sclerosis, and HIV. Owing to their distinct therapeutic properties and considerable potential in the contract active pharmaceutical ingredient (API) manufacturing sector, peptide contract development and manufacturing organizations (CDMOs) are emerging as a key segment of the market.

Market growth in the peptide CDMO sector is expected to be driven by factors such as advancements in healthcare infrastructure, expanding therapeutic applications of peptides, rising healthcare expenditures, and the development of innovative peptide design technologies. Additionally, increased utilization of peptides in drug development, growing R&D investments in peptide-based therapies, and the high prevalence of chronic diseases are contributing to market expansion. 

Enquiry Before Buying:

https://www.insightaceanalytic.com/enquiry-before-buying/1202

Regionally, North America, followed by Europe, is projected to lead the peptide CDMO (pharmaceutical) market during the forecast period (2022-2030), owing to the well-developing CDMOs, availability of peptide synthesis technologies, and the surging demand for peptides and drugs to treat chronic conditions.

Key market players operating in the peptide CDMO (pharmaceutical) market include AmbioPharm, Auspep, Bachem, BCN Peptide, CPC Scientific, CBL- Chemical and Biopharmaceutical Laboratories, ScinoPharm, Olon, Belyntic, Ferring Pharma, Numaferm, Hybio Pharmaceutical, Provepharm life solutions, Enzene Biosciences, Ardena Holding, Stelis Biopharma, Piramal Pharma, Space Peptides PharmaceuticalCreative Peptides, CSBio, Corden Pharma, PolyPeptide, Hybio Pharmaceutical, Peptide Institute, Pepscan, Almac, Chinese Peptide, CreoSalus Inc, Vivitide, Senn Chemicals, Wuxi AppTec, among others.

Key developments in the market:

·      In January 2022, CordenPharma collaborated with PeptiSystems, a Swedish-based developer of peptide and oligonucleotide therapeutic process development and manufacturing instruments, to reduce the footprint impact and improve the Process Mass Intensity (PMI) of peptide manufacturing processes.

·      In December 2021, Pepscan extended its column purification technology with a mid-sized column packer. This technology significantly reduces purification time and provides optimal flexibility when synthesizing peptides.

·      In September 2021, CEM Corporation and AmbioPharm, Inc. partnered to produce GMP peptides for the global market. The partnership will involve an exclusive1 use of CEM’s large-scale microwave peptide synthesis technology to produce GMP peptides up to multi-kilogram quantities using proprietary scalable reactors. Also, it will enable rapid and efficient production of peptide new chemical entities (NCE’s) using the latest technologies available.

·      In July 2021, CordenPharma expanded its peptide manufacturing capacity in CordenPharma Colorado, their GMP API facility in Boulder, CO (US). CordenPharma Colorado is the largest worldwide peptide API producer leading the global peptide market.

Get Specific Chapter/Information From The Report: @

https://www.insightaceanalytic.com/customisation/1202

Market Segments

Global Peptide CDMO (Pharmaceutical) Market, by Scale of Operation, 2025-2034 (Value US$ Mn)

·      Preclinical / Clinical

·      Commercial

Global Peptide CDMO (Pharmaceutical) Market, by Method Used, 2025-2034 (Value US$ Mn)

·      Chemical Synthesis Method

·      Non-Chemical Synthesis Method

Global Peptide CDMO (Pharmaceutical) Market, by By Applications, 2025-2034 (Value US$ Mn)

·      Peptide Supplements

·      Peptide Vaccines

·      Peptides as Radio-Theranostic Agents

·      Cell Penetrating Peptides (CPPs)

·      Affinity Ligands

·      Protein Mimics

Global Peptide CDMO (Pharmaceutical) Market, by Synthesis Types, 2025-2034 (Value US$ Mn)

·      LPPS

·      SPPS

·      Mixed Phase

Global Peptide CDMO (Pharmaceutical) Market, by Region, 2025-2034 (Value US$ Mn)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)

• The U.S.
• Canada

Europe Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

Get More Information :

https://www.insightaceanalytic.com/report/global-peptide-cdmo-pharmaceutical-market-/1202

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:

info@insightaceanalytic.com

InsightAce Analytic Pvt. Ltd.

Visit: www.insightaceanalytic.com

Tel : +1 607 400-7072

Asia: +91 79 72967118

Follow Us on LinkedIn @ bit.ly/2tBXsgS

Follow Us On Facebook @ bit.ly/2H9jnDZ

Twitter: https://twitter.com/Insightace